Rituxan and Diffuse large b-cell lymphoma recurrent - a phase IV clinical study of FDA data
Summary:
Diffuse large b-cell lymphoma recurrent is reported as a side effect among people who take Rituxan (rituximab), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Cytokine release syndrome.
The phase IV clinical study analyzes which people have Diffuse large b-cell lymphoma recurrent when taking Rituxan. It is created by eHealthMe based on reports of 64,282 people who have side effects when taking Rituxan from the FDA, and is updated regularly.
What is Rituxan?
Rituxan has active ingredients of rituximab. It is often used in rheumatoid arthritis. eHealthMe is studying from 64,791 Rituxan users. Check the latest studies of Rituxan.
What is Diffuse large b-cell lymphoma recurrent?
Diffuse large b-cell lymphoma recurrent (recurrent cancer of b cells, a type of white blood cell) is found to be associated with 74 drugs and 90 conditions by eHealthMe. Check the latest studies of Diffuse large b-cell lymphoma recurrent.
64,282 people reported to have side effects when taking Rituxan.
Among them, 140 people (0.22%) have Diffuse large b-cell lymphoma recurrent.
Among these 140 people:
How long have people been on Rituxan when they have Diffuse large b-cell lymphoma recurrent? *
What is the gender of people who have Diffuse large b-cell lymphoma recurrent when taking Rituxan? *
What is the age of people who have Diffuse large b-cell lymphoma recurrent when taking Rituxan? *
What are other drugs people take besides Rituxan? *
What are other side effects people have besides Diffuse large b-cell lymphoma recurrent? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Rituxan and have Diffuse large b-cell lymphoma recurrent?
- Check whether Diffuse large b-cell lymphoma recurrent is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Rituxan:
- Rituxan (64,791 reports)
Diffuse large b-cell lymphoma recurrent treatments and more:
- Diffuse large b-cell lymphoma recurrent (2,790 reports)
How severe was Diffuse large b-cell lymphoma recurrent and when was it recovered:
Expand to all the drugs that have ingredients of rituximab:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Rituxan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Diffuse large b-cell lymphoma recurrent:
- Diffuse large b-cell lymphoma recurrent (74 drugs)
Browse all the conditions that are associated with Diffuse large b-cell lymphoma recurrent:
- Diffuse large b-cell lymphoma recurrent (90 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on rituximab (the active ingredients of Rituxan) and Rituxan (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Psoriasis and Failure To Thrive - 4 seconds ago
- Could Apidra cause Dizziness Postural? - 5 seconds ago
- Drug interactions of Decadron and Prinivil - 6 seconds ago
- Drug interactions of Eurax and Atarax - 7 seconds ago
- Atenolol And Chlorthalidone vs. Zoloft, side effect and effectiveness comparison - 13 seconds ago
- Drug interactions of Ddavp and Zyprexa - 20 seconds ago
- Drug interactions of Losartan and Perphenazine - 22 seconds ago
- Mobic vs. Feldene, side effect and effectiveness comparison - 27 seconds ago
- Could Acetaminophen cause Pulmonary Aspergilloma (Mycetoma)? - 32 seconds ago
- Could Simvastatin cause Fluid Retention? - 33 seconds ago